Literature DB >> 22087023

Heme oxygenase-1 induction protects the heart and modulates cellular and extracellular remodelling after myocardial infarction in rats.

Päivi Lakkisto1, Juha-Matti Siren, Ville Kytö, Hanna Forsten, Mika Laine, Kari Pulkki, Ilkka Tikkanen.   

Abstract

Heme oxygenase-1 (HO-1) is a cytoprotective enzyme, which regulates cell proliferation and has potential antifibrogenic properties. In the present study, we investigated the effects of pre-emptive HO-1 induction by cobalt protoporphyrin IX on the healing of myocardial infarction in rats. The proliferation and repair of cardiac cells was assessed by immunostaining of Ki67 and proliferating cell nuclear antigen, and apoptosis of cardiomyocytes by terminal deoxynucleotidyl transferase dUTP nick end labelling. Compared with control hearts, HO-1 induction reduced apoptosis and increased proliferation and repair of cardiomyocytes in the infarct border area during the first few days after infarction. Concomitantly, HO-1 decreased accumulation and proliferation of fibroblasts, and down-regulated procollagen type I expression in the infarct area. Furthermore, HO-1 increased expression of the anti-inflammatory cytokine, transforming growth factor-β1, suggesting that the cardioprotective effect of HO-1 in the early phase of infarct healing may result partly from the suppression of the inflammatory response. In the remote myocardium, HO-1 inhibited both proliferation and apoptosis of cardiomyocytes, attenuated heart failure-induced increase in the repair of cardiomyocytes and decreased perivascular fibrosis, thereby potentially alleviating adverse ventricular remodelling. The cardioprotective effects of HO-1 in the late phase of infarct healing may be mediated partly by down-regulation of the profibrotic connective tissue growth factor (CTGF), as HO-1 decreased CTGF expression at week 4. In conclusion, our findings suggest an important role for HO-1 in maintaining cellular homeostasis in the postinfarction heart. Modulation of the HO-1 pathway may provide a new therapeutic approach to enhance the recovery of myocardial infarction and protect against pathological myocardial changes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22087023     DOI: 10.1258/ebm.2011.011148

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  18 in total

1.  Mitochondrial permeability transition triggers the release of mtDNA fragments.

Authors:  M Patrushev; V Kasymov; V Patrusheva; T Ushakova; V Gogvadze; A Gaziev
Journal:  Cell Mol Life Sci       Date:  2004-12       Impact factor: 9.261

2.  Can Cytoprotective Cobalt Protoporphyrin Protect Skeletal Muscle and Muscle-derived Stem Cells From Ischemic Injury?

Authors:  Heather-Marie P Wilson; Robert E Welikson; Jun Luo; Thomas J Kean; Baohong Cao; James E Dennis; Margaret D Allen
Journal:  Clin Orthop Relat Res       Date:  2015-09       Impact factor: 4.176

3.  Cobalt Protoporphyrin Upregulates Cyclooxygenase-2 Expression Through a Heme Oxygenase-Independent Mechanism.

Authors:  Hsiao-Yun Lin; Chon-Haw Tsai; Chingju Lin; Wei-Lan Yeh; Cheng-Fang Tsai; Pei-Chun Chang; Ling-Hsuan Wu; Dah-Yuu Lu
Journal:  Mol Neurobiol       Date:  2015-08-09       Impact factor: 5.590

4.  Fenofibrate Modulates HO-1 and Ameliorates Endothelial Expression of Cell Adhesion Molecules in Systolic Heart Failure.

Authors:  Wei-Hsian Yin; Jaw-Wen Chen; Yung-Hsiang Chen; Shing-Jong Lin
Journal:  Acta Cardiol Sin       Date:  2013-05       Impact factor: 2.672

5.  Heme oxygenase-1 upregulation modulates tone and fibroelastic properties of internal anal sphincter.

Authors:  Chadalavada Vijay Krishna; Jagmohan Singh; Sumit Kumar; Satish Rattan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-07-17       Impact factor: 4.052

6.  Heme levels are increased in human failing hearts.

Authors:  Arineh Khechaduri; Marina Bayeva; Hsiang-Chun Chang; Hossein Ardehali
Journal:  J Am Coll Cardiol       Date:  2013-03-06       Impact factor: 24.094

7.  Cobalt protoporphyrin pretreatment protects human embryonic stem cell-derived cardiomyocytes from hypoxia/reoxygenation injury in vitro and increases graft size and vascularization in vivo.

Authors:  Jun Luo; Matthew S Weaver; Baohong Cao; James E Dennis; Benjamin Van Biber; Michael A Laflamme; Margaret D Allen
Journal:  Stem Cells Transl Med       Date:  2014-04-15       Impact factor: 6.940

8.  Heme oxygenase 1 induction protects myocardiac cells against hypoxia/reoxygenation-induced apoptosis : The role of JNK/c-Jun/Caspase-3 inhibition and Akt signaling enhancement.

Authors:  C Li; C Zhang; T Wang; J Xuan; C Su; Y Wang
Journal:  Herz       Date:  2016-05-24       Impact factor: 1.443

9.  Targeting survival pathways to create infarct-spanning bridges of human embryonic stem cell-derived cardiomyocytes.

Authors:  Jun Luo; Matthew S Weaver; James E Dennis; Elizabeth Whalen; Michael A Laflamme; Margaret D Allen
Journal:  J Thorac Cardiovasc Surg       Date:  2014-07-24       Impact factor: 5.209

10.  Carnosic acid promotes myocardial antioxidant response and prevents isoproterenol-induced myocardial oxidative stress and apoptosis in mice.

Authors:  Bidya Dhar Sahu; Uday Kumar Putcha; Madhusudana Kuncha; Shyam Sunder Rachamalla; Ramakrishna Sistla
Journal:  Mol Cell Biochem       Date:  2014-06-06       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.